IMI to hold fourth quarter 2003 update webcast & conference call
Thursday March 4, 1:48 pm ET
TORONTO, March 4 /CNW/ - IMI International Medical Innovations Inc. (TSX: IMI, Amex: IME) today announced it will hold a conference call and webcast on Tuesday, March 9, 2004 at 10:30 a.m. (ET) to provide a corporate strategic update for the fourth quarter of fiscal 2003 and to preview year-end results.
The event will be hosted by Dr. Brent Norton, President and CEO; Ron Hosking, Vice President and CFO; and Sarah Borg-Olivier, Director, Communications. Please dial in five minutes prior to start time:
Date: Tuesday, March 9, 2004
Time: 10:30 a.m. ET
Webcast: www.imimedical.com or www.newswire.ca
Conference Call Numbers: (416) 640-4127 (Toronto)
(800) 814-4857 (North America)
A webcast will be accessible for three months at www.imimedical.com. A replay of the call will be available until March 16, 2004 by dialing (416) 640-1917 (Toronto) or (877) 289-8525 (North America) and entering access code 21041345 followed by the number sign.
IMI is a world leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection and monitoring of life-threatening diseases, particularly cardiovascular disease and cancer. IMI's lead product is a non-invasive skin test for coronary artery disease. IMI's cancer products in development include ColorectAlert(TM), a screening test for colorectal cancer, LungAlert(TM), a screening test for lung cancer, and a new test for breast cancer. For further information, please visit the company's website at www.imimedical.com.
newswire.ca
For further information
please contact Sarah Borg-Olivier, Director, Communications, (416) 222-3449 ext. 27, sbolivier@imimedical.com
--------------------------------------------------------------------------------
Source: IMI International Medical Innovations Inc. |
